Press Releases

May 27, 2016

Kite Pharma to Present at June 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at two investor conferences in June:

Jefferies 2016 Healthcare Conference

Date: Tuesday, June 7, 2016
Time: 11:00 AM EDT
Location: New York, NY

Goldman Sachs 37^th Annual Healthcare Conference

Date: Tuesday, June 7, 2016
Time: 11:20 AM PDT
Location: Palos Verdes, CA

A live audio webcast of both presentations will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160527005092/en/

Kite Pharma, Inc.
Greg Mann
VP, Investor Relations
gmann@kitepharma.com
or
For Media:
inVentiv Health
David Polk, 310-309-1029
david.polk@inventivhealth.com
or
Anne Cummings, 212-845-5632
anne.cummings@inventivhealth.com
or
Burns McClellan
Justin Jackson, 212-213-0006
jjackson@burnsmc.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media